MRSA

Influenza-MRSA Co-Infection May Require Vancomycin Plus Second Antibiotic

Influenza-MRSA Co-Infection May Require Vancomycin Plus Second Antibiotic

By

The early addition of a second anti-MRSA antibiotic to vancomycin may reduce mortality in severe cases of influenza-MRSA co-infection in children.

Penicillin Allergy Linked to MRSA, <i>C. Difficile</i> Risk

Penicillin Allergy Linked to MRSA, C. Difficile Risk

There is a correlation for documented penicillin allergy with increased risk of MRSA and C diff, which is mediated by increased use of β-lactam alternative antibiotics.

MRSA- and MSSA-Related Hospitalization Costs Assessed

MRSA- and MSSA-Related Hospitalization Costs Assessed

By

Increasing costs associated with hospitalizations involving MSSA infection are expected to surpass national costs for hospitalizations associated with MRSA.

Environmental Screening Effective Proxy for Evaluating MRSA and VRE Rate in Nursing Facilities

Environmental Screening Effective Proxy for Evaluating MRSA and VRE Rate in Nursing Facilities

By

Researchers assessed the ability of environmental screening as a proxy for patient colonization to reduce transmission of MRSA and VRE in nursing facilities.

Firvanq Availability Replaces Need for Compounded Oral Vancomycin Solution

Firvanq Availability Replaces Need for Compounded Oral Vancomycin Solution

By

FIRVANQ is commercially available in 25 and 50 mg/mL strengths in convenient 150 mL and 300 mL sizes.

<i>Staphylococcus aureus</i> in Patients Diagnosed With Bronchiectasis Without Cystic Fibrosis

Staphylococcus aureus in Patients Diagnosed With Bronchiectasis Without Cystic Fibrosis

By

In an attempt to determine if the presence of S aureus could be used as a marker for more severe disease, investigators assessed the relationship between S aureus-positive bronchiectasis infection and pulmonary function, frequency of exacerbations, and hospital admissions.

Treatment for MRSA Complicated Bacteremia and Infective Endocarditis

Treatment for MRSA Complicated Bacteremia and Infective Endocarditis

By

Further studies are warranted to assess the efficacy and safety of fosfomycin plus imipenem against methicillin-resistant Staphylococcus aureus complicated infections.

Antibiotic Stewardship: Role of MRSA Nasal Screening

Antibiotic Stewardship: Role of MRSA Nasal Screening

By

MRSA nares screening can be a stewardship tool to streamline empiric antibiotic therapy among those not nares colonized with MRSA.

SHEA Releases Contact Precaution Guidelines for Multidrug-Resistant Infections

SHEA Releases Contact Precaution Guidelines for Multidrug-Resistant Infections

By

A new expert guidance concerning contact precautions for multidrug resistant bacteria has been released.

Prevalence of MRSA in ICU Patients After State-Mandated Surveillance

Prevalence of MRSA in ICU Patients After State-Mandated Surveillance

By

The prevalence of methicillin-resistant Staphylococcus aureus colonization did not decline after implementation of state-legislated active surveillance among critically ill adults.

Treatment of Neurologic Complications in Infective Endocarditis

Treatment of Neurologic Complications in Infective Endocarditis

By

Mortality rates associated with infective endocarditis range from 16% to 25%, with the highest rates observed among patients with nosocomial healthcare-associated infective endocarditis.

Efficacy of Continuous vs Intermittent Vancomycin for Pediatric MRSA Infections Evaluated

Efficacy of Continuous vs Intermittent Vancomycin for Pediatric MRSA Infections Evaluated

By

Vancomycin administered via continuous infusion was found to achieve the recommended VAN trough of 15-20mg/L faster and with less risk of adverse events compared to administration via intermittent infusion.

Guidelines for Preventing Infections in Adolescent Athletes

Guidelines for Preventing Infections in Adolescent Athletes

By

Many of the recommendations by sports organizations are more stringent than ordinary infection control practices for similar conditions.

Methicillin-Susceptible <i>Staphyloccocus aureus</i> Carriers Unlikely to Acquire MRSA

Methicillin-Susceptible Staphyloccocus aureus Carriers Unlikely to Acquire MRSA

By

Study results can be used to support an antimicrobial stewardship policy discouraging empiric coverage for MRSA infections in a population of MSSA carriers.

Routine Evidence-Based Care for <i>S aureus</i> Infection Improves Survival

Routine Evidence-Based Care for S aureus Infection Improves Survival

By

Increase use of evidence-based care processes decreased mortality associated with S aureus bacteremia in VHA hospitals.

Treating Uncomplicated Cellulitis: Is Adding TMP/SMX Beneficial?

Treating Uncomplicated Cellulitis: Is Adding TMP/SMX Beneficial?

By

Adding trimethoprim-sulfamethoxazole to cephalexin treatment for cellulitis does not benefit outcomes compared to cephalexin alone.

Telavancin Efficacy Against Difficult-to-Treat Pathogens

Telavancin Efficacy Against Difficult-to-Treat Pathogens

By

Theravance Biopharma announced positive results from 3 studies on Vibativ (telavancin), a lipoglycopeptide antibiotic.

High Rates of Antibiotic Resistance in Infected Diabetic Foot Ulcers

High Rates of Antibiotic Resistance in Infected Diabetic Foot Ulcers

By

A carbapenem with vancomycin is the least resistant initial antibiotic combination to use in patients with an infected diabetic foot ulcer.

Hospital Room Floors May be Unrecognized Pathogen Dissemination Source

Hospital Room Floors May be Unrecognized Pathogen Dissemination Source

Disinfecting surfaces is key to preventing nosocomial transmission of pathogens such as C difficile, MRSA, and vancomycin-resistant enterococci.

Daptomycin Effective in Treating Serious Skin Infections in Children

Daptomycin Effective in Treating Serious Skin Infections in Children

By

Intravenous daptomycin may be effective and well-tolerated in children, possibly providing an alternative treatment against methicillin-resistant Staphylococcus aureus (MRSA) skin infections in this patient population.

Strategies for Reducing Hospital-Acquired Infections

Strategies for Reducing Hospital-Acquired Infections

By

Study finds that patients were 10% to 30% less likely to acquire a multidrug-resistant organism or C difficile if enhanced disinfection strategies were used in hospitals.

VA: MRSA Infection Rates on the Decline

VA: MRSA Infection Rates on the Decline

Researchers found that, over 8 years, MRSA health care-associated infection rates significantly declined.

Skin Infections From Drug Resistant <i>S aureus</i> Tied to Livestock

Skin Infections From Drug Resistant S aureus Tied to Livestock

A recent study found that hog workers in the North Carolina are developing skin infections from multidrug-resistant Staphylococcus aureus.

Antibiotics After Incision and Drainage Effective for Uncomplicated Skin Infections

Antibiotics After Incision and Drainage Effective for Uncomplicated Skin Infections

By

Clindamycin or TMP-SMX following I&D was more effective at curing Staphylococcus aureus infection in children and adults compared with placebo.

Prophages Can Prevent Invasiveness of <em>S aureus</em> Growth in Diabetic Foot Ulcers

Prophages Can Prevent Invasiveness of S aureus Growth in Diabetic Foot Ulcers

By

The use of prophages can reduce invasiveness in S aureus infections of diabetic foot ulcers that limit intracellular growth.

Staphylococcus aureus Nasal Colonization Associated With SLE Disease Phenotype

Staphylococcus aureus Nasal Colonization Associated With SLE Disease Phenotype

S aureus colonization was associated with particular SLE phenotypes.

Risk of <i>S. aureus</i> Bacteremia Increased in Patients on Glucocorticoids

Risk of S. aureus Bacteremia Increased in Patients on Glucocorticoids

Community-acquired Staphylococcus aureus bacteremia risk rose along with the dosage.

Is MRSA Incidence in Pediatric Populations Changing?

Is MRSA Incidence in Pediatric Populations Changing?

During study period, decrease noted in S. aureus susceptibility to clindamycin.

Community-Acquired Staph Bacteremia More Common in Diabetes Patients?

Community-Acquired Staph Bacteremia More Common in Diabetes Patients?

Risk up seven-fold among patients with type 1 diabetes, almost three-fold for those with type 2.

Trimethoprim-Sulfamethoxazole Better Than Placebo for Abscess

Trimethoprim-Sulfamethoxazole Better Than Placebo for Abscess

Higher clinical cure rate compared with placebo in setting in which MRSA was prevalent.

Sign Up for Free e-newsletters